News Celgene

Stocks

CELG

Delayed Nasdaq Other stock markets 04:00:00 2019-11-20 pm EST			5-day change	1st Jan Change
108.24 ^USD	+0.10%		-1.97%	+68.89%

23-06-14	Sutro Biopharma, Inc. Receives a Notice of Termination from Celgene Corporation	CI
21-09-07	Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential Settlement Agreement with Celgene Corporation	CI

All News

Mentions Relevance

22-08-24	Not What The Doctor Ordered: Authorisation Application Withdrawn For Pharma Patent Settlement In Australia	AQ
22-07-29	Authorisation request for proposed settlement between pharmaceutical companies withdrawn	AQ
21-08-04	Celgene : Sun Pharma And Celegene Settle Patent Dispute Over Lenalidomide (Revlimid®)	AQ
21-07-09	Besra Gold Inc: Announces Lodgment of Replacement Prospectus & Adjournment of Note Holder Meeting	NE
21-06-21	Celgene Corporation Will Grant Sun Pharmaceutical Industries Limited A License to Celgene's Patents Required to Manufacture and Sell Certain Limited Quantity	CI
21-04-14	Celgene : Rocket docket pharma patent litigation taking off in Australia and other emerging trends	AQ
21-04-07	DGAP-WpÜG: Tender Offer / Target company: ; Bidder: qqqqq	EQ
21-03-25	Leonteq becomes new issuer on BX Swiss – “deriBX”	TE
21-02-22	Celgene Corporation Issues Notice of Redemption of Notes	CI
20-07-07	BX Swiss AG receives approval from FINMA as Swiss Client Advisor Register	TE
20-07-03	Celgene : Parts Of Amended Patented Medicines Regulations Related To The PMPRB Struck Down	AQ
20-07-03	Furniture company mömax will be the new anchor tenant in the Rüti Center in Pratteln	TE
20-06-29	Celgene V. Sun Pharma Global: Satisfying Subject Matter Jurisdiction Under § 271(e)(2)	AQ
20-06-18	BX Swiss AG uses Blockchain technology to protect approved securities prospectuses against falsification	TE
20-05-28	BX Swiss AG receives approval from FINMA as a Prospectus Review Office	TE
20-01-06	GNS Healthcare, Inc. announced that it has received $28 million in funding from Cigna Ventures, Amgen Ventures, Celgene Corporation, Echo Health Ventures, Alexandria Venture Investments, LLC, Merck Global Health Innovation Fund, LLC, and another investor	CI
19-11-22	Celgene : Announces Plans to Transfer Listing of Celgene's Contingent Value Rights Following Closing of Acquisition by Bristol-Myers Squibb	AQ
19-11-22	Celgene : BONNEY MICHAEL W	PU
19-11-22	Celgene : CASEY MICHAEL D	PU
19-11-22	Celgene : FRIEDMAN MICHAEL A	PU
19-11-22	Celgene : COX CARRIE SMITH	PU
19-11-22	Celgene : LOUGHLIN JAMES J	PU
19-11-22	Celgene : HALLER JULIA A	PU
19-11-22	Celgene : REICIN ALISE	PU
19-11-22	Celgene : CURRAN TERRIE	PU

No results match your criteria

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Google lets you customize your preferred sources.

G Google

Choose MarketScreener

G Google

Choose MarketScreener